Kovack Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $570K | Buy |
1,280
+24
| +2% | +$10.7K | 0.06% | 296 |
|
|
2025
Q1 | $609K | Buy |
1,256
+19
| +2% | +$9.21K | 0.06% | 256 |
|
|
2024
Q4 | $498K | Sell |
1,237
-20
| -2% | -$8.05K | 0.05% | 302 |
|
|
2024
Q3 | $585K | Buy |
1,257
+45
| +4% | +$20.9K | 0.06% | 275 |
|
|
2024
Q2 | $568K | Buy |
1,212
+127
| +12% | +$59.5K | 0.06% | 278 |
|
|
2024
Q1 | $454K | Buy |
1,085
+5
| +0.5% | +$2.09K | 0.05% | 269 |
|
|
2023
Q4 | $439K | Buy |
1,080
+41
| +4% | +$16.7K | 0.05% | 329 |
|
|
2023
Q3 | $361K | Buy |
1,039
+76
| +8% | +$26.4K | 0.05% | 336 |
|
|
2023
Q2 | $339K | Sell |
963
-53
| -5% | -$18.7K | 0.04% | 387 |
|
|
2023
Q1 | $320K | Buy |
1,016
+71
| +8% | +$22.4K | 0.04% | 396 |
|
|
2022
Q4 | $273K | Buy |
945
+82
| +10% | +$23.7K | 0.04% | 426 |
|
|
2022
Q3 | $250K | Sell |
863
-802
| -48% | -$232K | 0.04% | 459 |
|
|
2022
Q2 | $469K | Sell |
1,665
-1,161
| -41% | -$327K | 0.06% | 329 |
|
|
2022
Q1 | $737K | Buy |
2,826
+721
| +34% | +$188K | 0.08% | 284 |
|
|
2021
Q4 | $462K | Buy |
+2,105
| New | +$462K | 0.04% | 404 |
|
|
2021
Q1 | – | Sell |
-1,094
| Closed | -$259K | – | 660 |
|
|
2020
Q4 | $259K | Sell |
1,094
-520
| -32% | -$123K | 0.04% | 451 |
|
|
2020
Q3 | $439K | Buy |
1,614
+136
| +9% | +$37K | 0.08% | 255 |
|
|
2020
Q2 | $429K | Buy |
1,478
+69
| +5% | +$20K | 0.08% | 239 |
|
|
2020
Q1 | $335K | Buy |
+1,409
| New | +$335K | 0.08% | 270 |
|
|
2019
Q3 | – | Sell |
-1,157
| Closed | -$212K | – | 498 |
|
|
2019
Q2 | $212K | Sell |
1,157
-256
| -18% | -$46.9K | 0.05% | 384 |
|
|
2019
Q1 | $260K | Sell |
1,413
-71
| -5% | -$13.1K | 0.06% | 323 |
|
|
2018
Q4 | $246K | Buy |
1,484
+60
| +4% | +$9.95K | 0.07% | 308 |
|
|
2018
Q3 | $274K | Buy |
+1,424
| New | +$274K | 0.07% | 313 |
|